Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable
Although the use of INSTIs has increased over time with differences in the duration of use, we did not observe a corresponding increase in the proportion of ARV-treated PLWHIV who experienced virological failure with INSTI-resistant viruses during the study period.
Authors
- Basma Abdi (ORCID: https://orcid.org/0000-0002-9139-0010)
- Elisa Teyssou
- Antoine Fayçal
- Christine Katlama (ORCID: https://orcid.org/0000-0002-5093-4800)
- Vincent Cálvez (ORCID: https://orcid.org/0009-0002-6855-3472)
- Romain Palich (ORCID: https://orcid.org/0000-0003-0047-0101)
- Anne‐Geneviève Marcelin (ORCID: https://orcid.org/0000-0003-4808-8999)
- Marc Wirden (ORCID: https://orcid.org/0009-0003-3723-4142)
- Marc‐Antoine Valantin
- Valérie Pourcher (ORCID: https://orcid.org/0000-0002-3879-1480)
- Sophie Sayon
- Antoine Fauchois
- Roland Tubiana
- Luminita Schneider
- Rachid Agher
- Cathia Soulié (ORCID: https://orcid.org/0009-0008-2032-4148)
Institutions
- Inserm (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1093/jac/dkaf454
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00